Using Ultra-Dense Array CGH to Find Cancer Gene Changes
Author Information
Author(s): Ewa Przybytkowski, Cristiano Ferrario, Mark Basik
Primary Institution: Lady Davis Institute, Sir Mortimer B. Davis Jewish General Hospital, McGill University
Hypothesis
Can ultra-dense array CGH effectively detect micro-copy number alterations and gene fusions in cancer genomes?
Conclusion
The study demonstrates that the 1 M array CGH platform can detect micro-CNAs and gene fusions with high sensitivity, but requires high-quality genomic DNA.
Supporting Evidence
- The 1 M array platform showed a 4-fold increase in resolution compared to the 244 K array.
- Fifteen micro-CNAs were detected only by the 1 M array, indicating its higher sensitivity.
- The study identified intra-genic breakpoints that may signal gene fusion events.
Takeaway
This study shows that a special DNA test can find tiny changes in cancer genes that might help doctors understand and treat cancer better.
Methodology
Array CGH was performed on whole genome amplified and non-amplified genomic DNA from MCF-7 breast cancer cells using 244 K and 1 M Agilent arrays.
Potential Biases
The use of whole genome amplification may introduce artifacts that confound the analysis.
Limitations
The study did not compare DNA from fresh or frozen cells versus that extracted from paraffin-embedded samples.
Participant Demographics
MCF-7 breast cancer cell line was used.
Statistical Information
P-Value
0.0055
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website